sl 84.0418 has been researched along with tolbutamide in 1 studies
Studies (sl 84.0418) | Trials (sl 84.0418) | Recent Studies (post-2010) (sl 84.0418) | Studies (tolbutamide) | Trials (tolbutamide) | Recent Studies (post-2010) (tolbutamide) |
---|---|---|---|---|---|
11 | 1 | 0 | 5,368 | 238 | 265 |
Protein | Taxonomy | sl 84.0418 (IC50) | tolbutamide (IC50) |
---|---|---|---|
Cytochrome P450 2C9 | Homo sapiens (human) | 0.392 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angel, I; Henquin, JC; Jonas, JC; Langer, SZ; Plant, TD | 1 |
1 other study(ies) available for sl 84.0418 and tolbutamide
Article | Year |
---|---|
In vitro stimulation of insulin release by SL 84.0418, a new alpha 2-adrenoceptor antagonist.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Diazoxide; Dioxanes; Electrophysiology; Female; Glucose; Idazoxan; In Vitro Techniques; Indoles; Insulin; Islets of Langerhans; Mice; Potassium Channels; Pyrroles; Rubidium Radioisotopes; Tolbutamide | 1994 |